Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

European stocks mixed; recession concerns clash with China reopening

Published 12/07/2022, 03:51 AM
Updated 12/07/2022, 03:51 AM
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com - European stock markets traded mixed Wednesday, as investors digested the further easing of COVID restrictions in China as well as regional recessionary concerns.

At 03:55 ET (08:55 GMT), the DAX index in Germany traded 0.1% lower, CAC 40 in France traded down 0.1%, while the FTSE 100 in the U.K. climbed 0.1%.

German industrial production fell less than expected in October, dropping 0.1% on the month, instead of the forecast 0.6% decrease, in part dragged down by a decrease in production in energy-intensive industrial sectors.

While this release offered relatively good news, European investors are still having to cope with anemic growth and tightening monetary policy to cope with stubbornly high inflation. 

Eurozone GDP is due later in the session, and is expected to show an economy that barely grew in the third quarter, climbing 0.2% on the quarter, while employment numbers are also due.

Additionally, the European Central Bank is expected to increase interest rates again next week, even if they are now "very near" their neutral level, according to ECB policymaker Constantinos Herodotou on Tuesday.

Analysts at Goldman Sachs see European stocks having a difficult start to 2023, after the strong rally to end this year. 

“We expect 2023 to prove tougher after the resilience in earnings this year,” said Goldman analysts, citing margin pressure due to higher costs that will be harder to pass on in a recession.

Chinese authorities announced earlier Wednesday that a range of COVID restrictions had been eased, including allowing some people to quarantine at home and ending test requirements to enter most public venues.

These moves follow civil unrest over the strict nature of the country’s mobility curbs to stem another outbreak of infections.

GSK (LON:GSK) stock soared 11% and Sanofi (NASDAQ:SNY) stock rose 7.4% after the drugmakers saw tens of thousands of lawsuits involving the heartburn medicine Zantac dismissed in a U.S. court.

Crude oil prices weakened Wednesday on worries over the global growth outlook, overshadowing the news of fewer new COVID-19 infections in China and the easing of a range of restrictions.

The American Petroleum Institute, an industry body, estimated a drawdown in U.S. crude stockpiles of around 6.4 million barrels last week, according to data released Tuesday, suggesting demand remained strong in the world’s largest consumer. 

The official numbers from the Energy Information Administration are due later Wednesday.

Trading has been volatile as the ramifications of the EU import ban and Group of Seven's $60-a-barrel price cap on seaborne Russian oil remain unclear.

By 03:55 ET, U.S. crude futures traded 0.5% lower at $73.88 a barrel, while the Brent contract traded 0.4% lower at $79.03, falling below $80 for the second time in 2022 during the previous trading session. 

Additionally, gold futures rose 0.3% to $1,787.85/oz, while EUR/USD traded 0.1% higher at 1.0476.

Latest comments

Covid, war, inflation and now recession. You only spread fear among people and enmity. And you help politicians to do so. Today, journalists have no shame or respect.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.